$1.59
-0.04-2.45%
Last update: Oct 1, 9:26 AM
$1.60
-0.03-1.84%
Innate Pharma SA
IPHANASDAQ
Wall Street analyst price targets and consensus rating for Innate Pharma (IPHA).
Price Target Range — 12 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months
